- Home
- APLT vs WKEY Comparison
APLT vs WKEY Comparison
Compare APLT & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- WKEY
- Stock Information
- Founded
- APLT 2016
- WKEY 1999
- Country
- APLT United States
- WKEY Switzerland
- Employees
- APLT N/A
- WKEY N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- WKEY EDP Services
- Sector
- APLT Health Care
- WKEY Technology
- Exchange
- APLT Nasdaq
- WKEY Nasdaq
- Market Cap
- APLT 63.6M
- WKEY 58.9M
- IPO Year
- APLT 2019
- WKEY N/A
- Fundamental
- Price
- APLT $0.42
- WKEY $5.94
- Analyst Decision
- APLT Buy
- WKEY Strong Buy
- Analyst Count
- APLT 6
- WKEY 1
- Target Price
- APLT $6.10
- WKEY $4.00
- AVG Volume (30 Days)
- APLT 883.6K
- WKEY 56.6K
- Earning Date
- APLT 11-06-2025
- WKEY 09-29-2025
- Dividend Yield
- APLT N/A
- WKEY N/A
- EPS Growth
- APLT N/A
- WKEY N/A
- EPS
- APLT N/A
- WKEY N/A
- Revenue
- APLT $121,000.00
- WKEY $11,875,000.00
- Revenue This Year
- APLT N/A
- WKEY $32.29
- Revenue Next Year
- APLT $5,931.24
- WKEY $89.83
- P/E Ratio
- APLT N/A
- WKEY N/A
- Revenue Growth
- APLT N/A
- WKEY N/A
- 52 Week Low
- APLT $0.30
- WKEY $1.61
- 52 Week High
- APLT $10.62
- WKEY $14.00
- Technical
- Relative Strength Index (RSI)
- APLT 38.92
- WKEY 63.14
- Support Level
- APLT $0.43
- WKEY $5.11
- Resistance Level
- APLT $0.46
- WKEY $5.46
- Average True Range (ATR)
- APLT 0.03
- WKEY 0.33
- MACD
- APLT -0.01
- WKEY 0.08
- Stochastic Oscillator
- APLT 0.35
- WKEY 80.56
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.